Skip to main content
MedPathMedPath Home
Clinical Trials/NCT04414683
NCT04414683
Recruiting
Not Applicable

Factors Affecting the Prognosis of Early Ovarian Cancer

Far Eastern Memorial Hospital1 site in 1 country300 target enrollmentApril 13, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOvarian Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ovarian Cancer
Sponsor
Far Eastern Memorial Hospital
Enrollment
300
Locations
1
Primary Endpoint
Factors affecting overall survival of early ovarian cancer
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

To elucidate factors affecting survival of early stage ovarian cancer

Detailed Description

To analyze factors affecting survival of early ovarian cancer, such as cell type, cell grade, intraoperative rupture, and laparoscopy vs. laparotomy, etc.

Registry
clinicaltrials.gov
Start Date
April 13, 2020
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sheng-Mou Hsiao

Chief of Department of Obstetrics & Gynecology

Far Eastern Memorial Hospital

Eligibility Criteria

Inclusion Criteria

  • •early stage ovarian cancer

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Factors affecting overall survival of early ovarian cancer

Time Frame: 10 years

Secondary Outcomes

  • Factors affecting progression-free survival of early ovarian cancer(10 years)

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
Anti-Mullerian Hormone (AMH) and Antral Follicle Count as Markers of Ovarian Reserve- Prospective Followup of Young Cancer PatientsInfertility
NCT00930501Hadassah Medical Organization100
Completed
Not Applicable
Early detection of ovarian cancer and response prediction: TEP and ctDNA study.
NL-OMON50170Catharina-ziekenhuis200
Unknown
Not Applicable
Intra-peritoneal Chemotherapy in Ovarian CancerOvarian NeoplasmsImmune ToleranceNeoplasmsEffects of Chemotherapy
NCT02861872Radboud University Medical Center15
Active, not recruiting
Not Applicable
Predicting risk of ovarian malignancy improved screening and early detection feasibility studyPrevention of ovarian cancerCancerMalignant neoplasm of ovary
ISRCTN54246466Queen Mary University of London140
Completed
Not Applicable
HIPEC in Ovarian Cancer, Case-Controls Study With 10-years Follow upOvarian CancerHIPEC
NCT04234243Instituto de Seguridad Social del Estado de Mexico y Municipios144